HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 197 filers reported holding HAEMONETICS CORP in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $319,658,666 | +5.1% | 3,567,781 | -0.1% | 0.29% | +7.0% |
Q2 2023 | $304,183,677 | +0.4% | 3,572,871 | -2.4% | 0.27% | -3.2% |
Q1 2023 | $302,910,086 | -0.6% | 3,661,736 | -5.5% | 0.28% | -6.0% |
Q4 2022 | $304,657,155 | +5.7% | 3,873,436 | -0.5% | 0.30% | -0.7% |
Q3 2022 | $288,209,000 | +18.9% | 3,893,389 | +4.7% | 0.30% | +23.4% |
Q2 2022 | $242,426,000 | +1.8% | 3,718,844 | -1.3% | 0.24% | +20.8% |
Q1 2022 | $238,238,000 | +16.1% | 3,769,086 | -2.8% | 0.20% | +25.5% |
Q4 2021 | $205,218,000 | -23.9% | 3,876,521 | +0.5% | 0.16% | -31.8% |
Q3 2021 | $269,677,000 | +8.2% | 3,856,498 | +2.6% | 0.24% | +8.8% |
Q2 2021 | $249,142,000 | -20.6% | 3,760,310 | +32.5% | 0.22% | -27.7% |
Q1 2021 | $313,849,000 | -6.5% | 2,837,486 | +0.2% | 0.30% | -13.8% |
Q4 2020 | $335,642,000 | +33.4% | 2,833,049 | -1.9% | 0.35% | +16.8% |
Q3 2020 | $251,659,000 | -9.4% | 2,888,690 | -6.9% | 0.30% | -13.6% |
Q2 2020 | $277,693,000 | +4.8% | 3,101,345 | +16.6% | 0.34% | -14.6% |
Q1 2020 | $264,992,000 | -11.7% | 2,658,957 | +1.8% | 0.40% | +15.4% |
Q4 2019 | $300,110,000 | +5.2% | 2,611,916 | +15.5% | 0.35% | +0.6% |
Q3 2019 | $285,257,000 | +8.8% | 2,261,433 | +3.8% | 0.35% | +10.8% |
Q2 2019 | $262,294,000 | +84.5% | 2,179,611 | +34.1% | 0.31% | +80.5% |
Q1 2019 | $142,176,000 | -0.1% | 1,625,242 | +14.2% | 0.17% | -12.1% |
Q4 2018 | $142,355,000 | -16.0% | 1,422,836 | -3.8% | 0.20% | +3.1% |
Q3 2018 | $169,500,000 | +24.6% | 1,479,314 | -2.4% | 0.19% | +28.0% |
Q2 2018 | $136,007,000 | +6.9% | 1,515,638 | -12.8% | 0.15% | +3.4% |
Q1 2018 | $127,279,000 | +12.6% | 1,738,933 | -10.6% | 0.14% | +11.5% |
Q4 2017 | $113,061,000 | +22.7% | 1,945,422 | -5.3% | 0.13% | +13.0% |
Q3 2017 | $92,139,000 | +25.2% | 2,053,458 | +10.2% | 0.12% | +21.1% |
Q2 2017 | $73,596,000 | -9.7% | 1,863,661 | -7.2% | 0.10% | -9.5% |
Q1 2017 | $81,476,000 | +11.1% | 2,008,284 | +10.1% | 0.10% | +7.1% |
Q4 2016 | $73,324,000 | +7.6% | 1,823,981 | -3.1% | 0.10% | +6.5% |
Q3 2016 | $68,140,000 | +22.2% | 1,881,814 | -2.2% | 0.09% | +19.5% |
Q2 2016 | $55,774,000 | -31.4% | 1,923,909 | -17.2% | 0.08% | -31.2% |
Q1 2016 | $81,288,000 | +5.6% | 2,323,856 | -2.7% | 0.11% | +10.9% |
Q4 2015 | $76,974,000 | -35.9% | 2,387,525 | -35.8% | 0.10% | -34.8% |
Q3 2015 | $120,156,000 | -30.0% | 3,717,686 | -10.4% | 0.16% | -18.8% |
Q2 2015 | $171,670,000 | -15.6% | 4,150,626 | -8.3% | 0.19% | -12.0% |
Q1 2015 | $203,334,000 | +11.1% | 4,526,580 | -7.4% | 0.22% | +14.2% |
Q4 2014 | $182,973,000 | +1.6% | 4,889,723 | -5.1% | 0.19% | +2.7% |
Q3 2014 | $180,003,000 | -7.6% | 5,154,730 | -6.7% | 0.18% | -2.6% |
Q2 2014 | $194,839,000 | +5.3% | 5,522,650 | -2.7% | 0.19% | +1.1% |
Q1 2014 | $185,008,000 | -23.3% | 5,676,833 | -0.8% | 0.19% | -24.2% |
Q4 2013 | $241,191,000 | -48.5% | 5,724,923 | -38.4% | 0.25% | -11.4% |
Q3 2013 | $467,967,000 | +83.3% | 9,288,936 | +50.5% | 0.28% | -7.9% |
Q2 2013 | $255,291,000 | – | 6,173,902 | – | 0.30% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
LGT CAPITAL PARTNERS LTD. | 1,216,059 | $64,500,000 | 1.72% |
HEARTLAND ADVISORS INC | 406,192 | $21,544,000 | 1.26% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 200,000 | $10,608,000 | 1.22% |
Aurora Investment Counsel | 32,149 | $1,705,000 | 1.01% |
Endurant Capital Management LP | 73,914 | $3,920,000 | 0.95% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 135,000 | $7,160,000 | 0.82% |
ARMISTICE CAPITAL, LLC | 872,000 | $46,251,000 | 0.76% |
Summit Creek Advisors LLC | 131,357 | $6,967,000 | 0.70% |
Dean Capital Management | 15,309 | $812,000 | 0.70% |
Keene & Associates, Inc. | 11,720 | $622,000 | 0.54% |